STIMUNITY
Stimunity is a preclinical-stage startup company which develops best-in-class drugs on the STING pathway to activate the innate immune system. Their drugs stimulate patients' immune system to fight back infectious pathogens or cancer.
STIMUNITY
Social Links:
Industry:
Biotechnology Health Care
Founded:
2016-02-24
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.stimunity.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.5 M EUR
Technology used in webpage:
Amazon
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Founder
Investors List
Portage Biotech
Portage Biotech investment in Seed Round - Stimunity
Portage Biotech
Portage Biotech investment in Seed Round - Stimunity
Portage Biotech
Portage Biotech investment in Seed Round - Stimunity
Official Site Inspections
http://www.stimunity.com Semrush global rank: 10.78 M Semrush visits lastest month: 201
- Host name: server-3-167-56-118.iad61.r.cloudfront.net
- IP address: 3.167.56.118
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Stimunity"
Stimunity — Boost Immunity
Stimunity is a preclinical-stage startup company which develops best-in-class drugs on the STING pathway to activate the innate immune system. Our drugs stimulate patients' immune system …See details»
Stimunity - Crunchbase Company Profile & Funding
Organization. Stimunity . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Stimunity is an early …See details»
Stimunity Company Profile 2024: Valuation, Funding & Investors
Stimunity General Information Description. Operator of a biotechnology company intended to develop STING agonists in cancer. The company's technology provides a biological approach …See details»
Stimunity - Funding, Financials, Valuation & Investors - Crunchbase
Stimunity is an early-stage research and development company focused on the development of STING agonists in cancer. New. Resources. Advanced Search. ... How much funding has this …See details»
Stimunity Reaches Major Milestone and Secures Next Round of …
Stimunity’s first stage of the preclinical development plan was to unlock the mechanism of action of its main biological drug cGAMP-VLP (STI-001) and to reveal its therapeutic potential in …See details»
Stimunity - Contacts, Employees, Board Members, Advisors
Stimunity is an early-stage research and development company focused on the development of STING agonists in cancer. New. Resources. Advanced Search. Start Free Trial . Talk With …See details»
Stimunity - VentureRadar
Stimunity is a preclinical-stage startup company which develops best-in-class drugs on the STING pathway to activate the innate immune system. Our drugs stimulate patients' immune system …See details»
Stimunity Company Information - Funding, Investors, and More
Stimunity is active in the following industries: Biopharmaceutical; Health technology; Deep Tech; Technology; Healthcare; Biotechnology; Biology; Biomedical engineering; Engineering; Track …See details»
Stimunity secures 2M€ from Portage to advance preclinical …
Changer in the immunotherapy field. “The collaboration between Stimunity and Portage opens another chapter for Portage, providing the company with a program advancing into human …See details»
Stimunity - Overview, News & Similar companies | ZoomInfo.com
Stimunity is an early-stage biotech company focused on the development of STING agonist in immune-oncology based on a Virus-Like Particle, a unique biological approach. The …See details»
Stimunity - Updates, News, Events, Signals & Triggers - Crunchbase
Stimunity is an early-stage research and development company focused on the development of STING agonists in cancer. Search Crunchbase. ... Solutions. Products. Resources. Pricing. …See details»
Turn Cancer Immunotherapy Effective in Most Patients
Aug 17, 2022 Stimunity is a company that develops disruptive immuno-stimulatory biological drugs to restore the immune system against tumor cells.Immune checkpoint inhibitors showed …See details»
Stimunity Signs an Exclusive License Agreement with Institut Curie …
Paris, March 21st, 2017 – Stimunity, Institut Curie and Inserm are pleased to announce that the company has signed an exclusive worldwide license agreement on two key patents that cover …See details»
☑️Stimunity — Consulting Organization from France, experience …
Stimunity — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health sector. Our website uses cookies to enable essential features …See details»
NEWS RELEASE PORTAGE INVESTS IN STIMUNITY S.A, A PARIS …
NEWS RELEASE PORTAGE INVESTS IN STIMUNITY S.A, A PARIS-BASED CANCER IMMUNOTHERAPY COMPANY. Toronto, Ontario, February 28th, 2018 – Portage Biotech Inc. …See details»
Portage Makes Additional Investment in Stimunity S.A, a Paris …
Mar 28, 2019 Stimunity has also secured a €50k non-dilutive financing from Paris Île-de-France "Innov'up Developpement" to help advancing on its second generation of drug STI-002 based …See details»
Stimunity - Crunchbase
Stimunity is an early-stage research and development company focused on the development of STING agonists in cancer. New. Resources. Advanced Search. Start Free Trial . Talk With …See details»
Stimunity Raises Additional Capital to Secure its Path to the Clinic
Stimunity is an early-stage research and development company focused on the development of STING agonists in cancer. The technology, licensed from Institut Curie, Inserm, and University …See details»
Stimunity AACR 2022 VF
Stimunity Announces Presentation of STI-001 Preclinical Work at AACR 2022 Paris, April 2022 – Stimunity, the VLP-based cancer immunotherapy company focused on STING, is pleased to …See details»